Merck/Roche Co-Promote Pact Attempts To Shut Vertex Out Of HCV Protease Inhibitor Space
This article was originally published in The Pink Sheet Daily
Executive Summary
Roche will co-promote Merck's Victrelis with its own HCV drugs Pegasys and Copegus in the U.S.